Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of Antidiabetics

QR Code

Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of Antidiabetics

Introduction: In previous studies carried out in our laboratory, a bile acid (BA) formulation exerted a hypoglycaemic effect in a rat model of type-1 diabetes (T1D). When the antidiabetic drug gliclazide (G) was added to the bile acid, it augmented the hypoglycaemic effect. In a recent study, we des...

Full description

Bibliographic Details
Main Authors:	Mooranian, Armin, Negrulj, Rebecca, Mathavan, Sangeetha, Martinez, Jorge, Sciarretta, Jessica, Chen-Tan, Nigel, Mukkur, Trilochan, Mikov, Momir, Lalic-Popovic, M., Stojancevic, M., Golocorbin-Kon, S., Al-Salami, Hani
Format:	Journal Article
Published:	Springer New York LLC 2014
Subjects:	Bile acid Gliclazide Artificial-cell microencapsulation Diabetes
Online Access:	http://hdl.handle.net/20.500.11937/14090

Similar Items

Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: A Characterization Study
by: Mooranian, Armin, et al.
Published: (2014)

Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats
by: Al-Salami, Hani, et al.
Published: (2009)

Potentials and Limitations of Bile Acids in Type 2 Diabetes Mellitus: Applications of Microencapsulation as a Novel Oral Delivery System
by: Negrulj, Rebecca, et al.
Published: (2013)

Probucol Release from Novel Multicompartmental Microcapsules for the Oral Targeted Delivery in Type 2 Diabetes
by: Mooranian, Armin, et al.
Published: (2014)

Application of bile acids in drug formulation and delivery
by: Stojancevic, M., et al.
Published: (2014)

An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer
by: Mooranian, Armin, et al.
Published: (2014)

Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol
by: Mooranian, Armin, et al.
Published: (2014)

An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniques
by: Mooranian, Armin, et al.
Published: (2019)

An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations
by: Mooranian, A., et al.
Published: (2015)

Correlation between in vitro tests for blood brain barrier penetration with in vivo gliclazide penetration
by: Lalic-Popovic, M., et al.
Published: (2013)

Deoxycholic Acid as a Modifier of the Permeation of Gliclazide through the Blood Brain Barrier of a Rat
by: Lalic-Popovic, M., et al.
Published: (2013)

Pharmacokinetic and Drug Absorption Profiles of the Anti-Hyperglycaemic Agent Gliclazide in Oral Tissue-Targeted Microcapsules in Rats
by: Jovic, Jelena, et al.
Published: (2020)

THE EFFECT OF BILE ACID SALT SODIUM 3ALPHA, 7ALPHA-DIHYDROXY-12-KETO-5BETA-CHOLANATE (MKC) AND PROBIOTIC PRETREATMENT ON GLICLAZIDE PERMEATION IN ILEAL TISSUES FROM HEALTHY AND DIABETIC RATS
by: Mikov, M., et al.
Published: (2014)

Microencapsulation of Bifidobacterium pseudocatenulatum G4 using natural matrices
by: Abdul Khalil, Khalilah
Published: (2012)

Microencapsulation of Betacyanin extract from amaranth
by: Chong, Pik Han
Published: (2015)

Properties of alginate-chitosan microcapsule containing tocotrienols in self-assembled pickering emulsion and its stability in yogurt
by: Tan, Phui Yee
Published: (2017)

The applications of microencapsulated formulation of gliclazide and bile acids in Type-1 diabetes mellitus
by: Mathavan, Sangeetha
Published: (2017)

Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment
by: Mooranian, Armin, et al.
Published: (2015)

Design And Evaluation Of Prolonged Release Gliclazide Matrix Tablets.
by: Abdelraziq Abdelkareem Adam, Fathelrahman
Published: (2007)

High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect
by: Golocorbin-Kon, S., et al.
Published: (2017)

Species Classification and Molecular Studies of Bile Salt Hydrolase (BSH) Gene in Bifidobacterium Spp
by: Mustafa, Shuhaimi
Published: (2003)

Development And Evaluation Of A Matrix Controlled-release Formulation Of Gliclazide
by: Adebaibi, Mahmoud
Published: (2008)

Encapsulation of tamoxifen and magnetic nanoparticles in poly lactic acid using supercritical antisolvent process
by: Alias, Dalila
Published: (2020)

Combination of xanthan gum and HPMC as retardants in sustained release gliclazide formulation
by: Othman, Liyana Zafirah, et al.
Published: (2017)

Diabetes and hypertension increase the placental and transcellular permeation of the lipophilic drug diazepam in pregnant women
by: Lalic-Popovic, M., et al.
Published: (2013)

Optimization of Freeze-Drying Protectants by Response Surface Methodology and Encapsulation for Bifidobacterium Pseudocatenulatum G4 and Lactobacillus Acidophilus LA-5 Survival Enhancement
by: Teoh, Peck Lian
Published: (2011)

Optimization of process conditions and emulsion composition, and their effects on emulsion and encapsulation properties of spray-dried fish oil powder
by: Tirgar, Mina
Published: (2012)

Microencapsulated Nigella sativa L. oil as functional ingredient for non-dairy creamer
by: Mohammed, Nameer Khairullah
Published: (2018)

Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment (vol 32, pg 151, 2014)
by: Mooranian, A., et al.
Published: (2015)

Alginate-combined cholic acid increased insulin secretion of microencapsulated mouse cloned pancreatic ß cells
by: Mooranian, A., et al.
Published: (2017)

Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes
by: Negrulj, R., et al.
Published: (2015)

Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles
by: Pavlovic, N., et al.
Published: (2018)

Characterisation of red palm oil microcapsule with solution-enhanced dispersion by supercritical carbon dioxide technology
by: Lee, Wan Jun
Published: (2018)

Effect of microencapsulation efficiency of maltodextrin produced from breadfruit and broken rice and its in vitro wound healing efficacy
by: Mohamed Amin, Zahiah
Published: (2015)

Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats
by: Al-Salami, Hani, et al.
Published: (2012)

Development of generic gliclazide 60 mg modified release tablets using central composite design
by: Elsayed, Tarek Mohamed Ali, et al.
Published: (2015)

Preliminary study on the formulation of syariah compliant generic sustained release gliclazide tablet using xanthan gum
by: Mat Zin, Nik Mohamad Lukman, et al.
Published: (2016)

Preliminary study on the formulation of syariah compliant generic sustained release gliclazide tablet using xanthan gum
by: Mat Zin, Nik Mohamad Lukman, et al.
Published: (2018)

The role of Proline-Rich Homeodomain protein PRH/HHEX in cholangiocarcinoma
by: Ghouth, Nahlah
Published: (2024)

Investigating the bile acid mediated control of Clostridioides difficile infection
by: von Emloh, Louise
Published: (2024)

Cannot write session to /tmp/vufind_sessions/sess_nbtm89e9q3uo81jdp3d23pbift